# Use of CBCT to Improve Inferior Alveolar Nerve Block Success

> **NCT05406895** · NA · COMPLETED · sponsor: **Louisiana State University Health Sciences Center in New Orleans** · enrollment: 2 (actual)

## Conditions studied

- Inferior Alveolar Nerve
- Mandibular Nerve Blocks

## Interventions

- **DRUG:** 2% Lidocaine with 1:100,000 epinephrine

## Key facts

- **NCT ID:** NCT05406895
- **Lead sponsor:** Louisiana State University Health Sciences Center in New Orleans
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-05-25
- **Primary completion:** 2024-03-30
- **Final completion:** 2024-03-30
- **Target enrollment:** 2 (ACTUAL)
- **Last updated:** 2024-05-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05406895

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05406895, "Use of CBCT to Improve Inferior Alveolar Nerve Block Success". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05406895. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*